The therapy involves taking stem cells out of a patient's bone marrow and editing a gene in the cells in a laboratory and ...

We recently published a list of 9 Stocks Jim Cramer Talked About. In this article, we are going to take a look at where ...

NHS officials estimate that around 50 people a year will receive treatment now that it has been approved for use for certain ...

Australian cancer researchers are the first to establish a next-generation gene-editing tool for modeling and interrogating ...

SG Americas Securities LLC decreased its holdings in CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 17.9% during the 4th quarter, according to the company in its most recent disclosure with the ...

EditCo Bio, a leader in cutting-edge genetic engineering and cellular model solutions, today announced the launch of XDel Knockout Cells, an innovative product designed to revolutionize the field of ...

NHS patients with sickle cell disease will be able to benefit from a groundbreaking gene-editing treatment that offers the prospect of a cure for the condition. The one-off gene therapy, known as ...

In the closing of the recent trading day, CRISPR Therapeutics AG (CRSP) stood at $41.21, denoting a -1.44% change from the preceding trading day. ZUG, Switzerland and BOSTON, Jan. 29, 2025 (GLOBE ...

Sublingual Allergy Immunotherapy Market The rising of allergic diseases, such as allergic rhinitis and asthma, is a factor driving the grow ...

Australian cancer researchers are the first to establish a next-generation gene-editing tool for modelling and interrogating human disease.